09/03/2026
A new CMS measure could change how your facility’s antipsychotic rates are reported—even if prescribing practices haven’t changed.
Effective January 2026, CMS implemented a new hybrid Long-Stay Antipsychotic Quality Measure designed to more accurately identify antipsychotic use. For some facilities, the change may result in higher reported rates—potentially impacting Five-Star ratings, Care Compare results, and survey scrutiny.
During this session, attendees will learn what has changed, why reported rates may increase, and how interdisciplinary teams can strengthen documentation, coding, appropriate medication use, and regulatory compliance.
Prepare your team for what the new measure means before your next survey. 👉 Register today: https://okt.to/2mFJRu